We are live on !
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$566M
Turnover
17.35%
1-Year Est. Return
197.74%
This Fund
S&P 500
This Quarter Est. Return
+96.59%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
–
AUM
$566M
AUM Growth
+$191M
(+51%)
Cap. Flow
-$25.1M
Cap. Flow % of AUM
Cap. Flow %
-4.43%
Top 10 Holdings %
Top 10 Hldgs %
65.92%
Holding
98
New
12
Increased
27
Reduced
22
Closed
5
Avg Time Held
Equity + Options
2.4
years
Top 10 Avg Time Held
Equity + Options
2
years
Top 20 Avg Time Held
Equity + Options
2.3
years
Avg Time Held Equity only
2.8
years
Top 10 Avg Time Held Equity only
2.3
years
Top 20 Avg Time Held Equity only
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$5.33M |
| 2 |
HELP
Helus Pharma Inc. Common Stock
HELP
|
+$3.72M |
| 3 |
Microsoft
MSFT
|
+$3.33M |
| 4 |
Immuneering
IMRX
|
+$3.28M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$1.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$37.5M |
| 2 |
Eli Lilly
LLY
|
+$5.72M |
| 3 |
Cisco
CSCO
|
+$1.57M |
| 4 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$1.52M |
| 5 |
Ionis Pharmaceuticals
IONS
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.15% |
| 2 | Technology | 31.31% |
| 3 | Healthcare | 17.63% |
| 4 | Communication Services | 4.62% |
| 5 | Consumer Discretionary | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
LENSAR
LNSR
$72.7M
| $675K | 0.12% |
118,217
| – | – |
2020 Q4
22 quarters
|
|
77
Turning Point Brands
TPB
$1.35B
| $636K | 0.11% |
7,500
+500
| +7% | +$41.5K |
2023 Q2
12 quarters
|
|
78
Savara
SVRA
$1.03B
| $616K | 0.11% |
+100,000
| New | +$537K |
2026 Q2
0 quarters
|
|
79
AnaptysBio
ANAB
$1.51B
| $615K | 0.11% |
9,114
-9,661
| -51% | -$586K |
2025 Q1
5 quarters
|
|
80
O-I Glass
OI
$865M
| $578K | 0.1% |
60,000
| – | – |
2023 Q1
13 quarters
|
|
81
Home Depot
HD
$317B
| $529K | 0.09% |
+1,500
| New | +$488K |
2026 Q2
0 quarters
|
|
82
Spotify
SPOT
$111B
| $528K | 0.09% |
1,150
-100
| -8% | -$47.7K |
2023 Q1
13 quarters
|
|
83
InflaRx
IFRX
$255M
| $512K | 0.09% |
228,500
+70,000
| +44% | +$132K |
2025 Q4
2 quarters
|
|
|
84
CALL
Amazon
AMZN
$2.75T
| $477K | 0.08% |
2,000
-500
| -20% | -$126K |
2026 Q1
1 quarter
|
|
85
CALL
Sanofi
SNY
$101B
| $427K | 0.08% |
10,000
+4,500
| +82% | +$201K |
2026 Q1
1 quarter
|
|
86
ServiceNow
NOW
$155B
| $372K | 0.07% |
+3,750
| New | +$371K |
2026 Q2
0 quarters
|
|
87
Teladoc Health
TDOC
$1.25B
| $360K | 0.06% |
+42,500
| New | +$283K |
2026 Q2
0 quarters
|
|
88
CALL
iShares Bitcoin Trust
IBIT
$66.4B
| $316K | 0.06% |
9,500
+2,000
| +27% | +$81.4K |
2026 Q1
1 quarter
|
|
89
Medtronic
MDT
$121B
| $235K | 0.04% |
+3,000
| New | +$242K |
2026 Q2
0 quarters
|
|
90
CALL
Zoom
ZM
$29.3B
| $129K | 0.02% |
+1,500
| New | +$142K |
2026 Q2
0 quarters
|
|
91
CALL
Altimmune
ALT
$408M
| $112K | 0.02% |
37,000
| – | – |
2025 Q4
2 quarters
|
|
92
Ardelyx
ARDX
$800M
| $112K | 0.02% |
22,000
+2,000
| +10% | +$12.2K |
2025 Q2
4 quarters
|
|
|
93
Altimmune
ALT
$408M
| $44.7K | 0.01% |
14,700
| – | – |
2025 Q4
2 quarters
|
|
|
94
PUT
Cisco
CSCO
$435B
| – | – |
-15,000
| Closed | -$1.16M | – |
|
95
PUT
VanEck Semiconductor ETF
SMH
$71B
| – | – |
-32,000
| Closed | -$12.3M | – |
|
96
CALL
Synopsys
SNPS
$92.3B
| – | – |
-500
| Closed | -$198K | – |
|
|
97
Synopsys
SNPS
$92.3B
| – | – |
-1,250
| Closed | -$496K | – |
|
|
98
PUT
Spotify
SPOT
$111B
| – | – |
-1,000
| Closed | -$485K | – |
|
Similar funds
LT
DCF Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, DCF Advisers held 98 positions worth $566M, up 51% from $375M the previous quarter. Its ten largest holdings account for 66% of the portfolio.
DCF Advisers withdrew a net $25.1M in Q2 2026, closing 5 positions and reducing 22 holdings. Its most notable exit was Synopsys, an estimated $496K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.
Against the trend, DCF Advisers opened a new position in MarineMax worth $2.11M.
- DCF Advisers's largest Q2 2026 buy was MarineMax: 57,500 shares worth $2.11M.
- DCF Advisers added most to Amazon in Q2 2026, an estimated $5.33M increase.
- DCF Advisers's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $37.5M.
- DCF Advisers fully exited Synopsys in Q2 2026, selling an estimated $496K.
- DCF Advisers's ten largest holdings make up 66% of its $566M portfolio in Q2 2026.
- DCF Advisers opened 12 new positions and closed 5 in Q2 2026.
- DCF Advisers's portfolio value rose 51% quarter-over-quarter to $566M.
Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.